PFG
52
7
AMT
59
13
NTRS
52
7
ZION
55
7
KLAC
63
6
AIG
83
3
THC
56
2
C
51
3
ILMN
28
-2
KEY
39
13
OI
43
4
CLX
68
2
PNW
73
2
EQT
59
5
MHK
42
-6
FOXA
56
4
WMB
60
4
SNA
46
3
CTAS
45
5
CFG
50
14
PFG
52
7
AMT
59
13
NTRS
52
7
ZION
55
7
KLAC
63
6
AIG
83
3
THC
56
2
C
51
3
ILMN
28
-2
KEY
39
13
OI
43
4
CLX
68
2
PNW
73
2
EQT
59
5
MHK
42
-6
FOXA
56
4
WMB
60
4
SNA
46
3
CTAS
45
5
CFG
50
14
Financhill
Back

AnaptysBio 10K Form

Sell
28

ANAB
AnaptysBio

Last Price:
$16.76
Seasonality Move:
-3.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-02 10Q ANAB/AnaptysBio Quarterly
2023-08-07 10Q ANAB/AnaptysBio Quarterly
2023-05-11 10Q ANAB/AnaptysBio Quarterly
2022-11-08 10Q ANAB/AnaptysBio Quarterly
2022-08-08 10Q ANAB/AnaptysBio Quarterly
2022-05-04 10Q ANAB/AnaptysBio Quarterly

Receive ANAB News And Ratings

See the #1 stock for the next 7 days that we like better than ANAB

ANAB Financial Statistics

Sales & Book Value

Annual Sales: $91.3M
Cash Flow: $-66.9M
Price / Cash Flow: 0
Annual Sales: $2.33
Price / Book: 7.24

Profitability

EPS (TTM): -5.21000
Net Income (TTM): $-145.2M
Gross Margin: $5.5M
Return on Equity: -241.25%
Return on Assets: -32.09%

AnaptysBio Earnings Forecast

Key AnaptysBio Financial Ratios

  • The Gross Profit Margin over the past 1 years for ANAB is 99.95%.
  • The Selling, General & Administrative Expenses for ANAB have been equal to 46.44% of Gross Profit Margin.
  • The Research & Development expenses have been 179.49% of Revenue.
  • The Net Earning history of ANAB is -159.10% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 4 years.

AnaptysBio Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ANAB
CUSIP: 032724
Website: anaptysbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 9.51
Quick Ratio: 9.38

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ANAB Technical Analysis vs Fundamental Analysis

Sell
28
AnaptysBio (ANAB) is a Sell

Is AnaptysBio a Buy or a Sell?

  • AnaptysBio stock is rated a Sell
    The current AnaptysBio [ANAB] share price is $16.73. The Score for ANAB is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.